Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
出版年份 2013 全文链接
标题
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
作者
关键词
-
出版物
LEUKEMIA
Volume 27, Issue 8, Pages 1677-1687
出版商
Springer Nature
发表日期
2013-01-30
DOI
10.1038/leu.2013.28
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma
- (2012) E. Tiacci et al. BLOOD
- Phase II study of sorafenib in patients with relapsed or refractory lymphoma
- (2012) Anna Guidetti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New therapeutic targets and treatment strategies
- (2012) Paula Cramer et al. Nature Reviews Clinical Oncology
- Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
- (2012) Giulia Pinton et al. PLoS One
- AIF-mediated caspase-independent necroptosis requires ATM and DNA-PK-induced histone H2AX Ser139 phosphorylation
- (2012) M Baritaud et al. Cell Death & Disease
- Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression
- (2011) Young-Sun Kim et al. BIOCHEMICAL PHARMACOLOGY
- Sorafenib Enhances Pemetrexed Cytotoxicity through an Autophagy-Dependent Mechanism in Cancer Cells
- (2011) M. D. Bareford et al. CANCER RESEARCH
- Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy
- (2011) D Vara et al. CELL DEATH AND DIFFERENTIATION
- Perifosine Plus Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With Bortezomib: Results of a Multicenter Phase I/II Trial
- (2011) Paul G. Richardson et al. JOURNAL OF CLINICAL ONCOLOGY
- Oncogenic Stress Induced by Acute Hyper-Activation of Bcr-Abl Leads to Cell Death upon Induction of Excessive Aerobic Glycolysis
- (2011) Michael A. Dengler et al. PLoS One
- Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature
- (2010) C. Lavazza et al. BLOOD
- Necroptosis as an alternative form of programmed cell death
- (2010) Dana E Christofferson et al. CURRENT OPINION IN CELL BIOLOGY
- Emerging drugs for Hodgkin's lymphoma
- (2010) Boris Böll et al. EXPERT OPINION ON EMERGING DRUGS
- Developments in the management of Hodgkin's lymphoma
- (2010) Lisa Lowry et al. LANCET
- Inhibition of MEK/ERK1/2 sensitizes lymphoma cells to sorafenib-induced apoptosis
- (2010) Tri K. Nguyen et al. LEUKEMIA RESEARCH
- Beyond chemotherapy: new agents for targeted treatment of lymphoma
- (2010) Anas Younes Nature Reviews Clinical Oncology
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
- (2009) David T. Teachey et al. BRITISH JOURNAL OF HAEMATOLOGY
- Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma
- (2009) Michael Dickinson et al. BRITISH JOURNAL OF HAEMATOLOGY
- Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma
- (2009) Alison J. Moskowitz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy
- (2009) L. Fu et al. CANCER RESEARCH
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
- (2009) YoungSik Cho et al. CELL
- In vivo Antitumor Activity of MEK and Phosphatidylinositol 3-Kinase Inhibitors in Basal-Like Breast Cancer Models
- (2009) K. P. Hoeflich et al. CLINICAL CANCER RESEARCH
- Sorafenib and Vorinostat Kill Colon Cancer Cells by CD95-Dependent and -Independent Mechanisms
- (2009) T. Walker et al. MOLECULAR PHARMACOLOGY
- Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib
- (2009) Constantine S. Mitsiades et al. SEMINARS IN HEMATOLOGY
- Perifosine: Update on a novel Akt inhibitor
- (2009) Joell J. Gills et al. Current Oncology Reports
- Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma
- (2009) A. Younes Hematology-American Society of Hematology Education Program
- Perifosine induces differentiation and cell death in prostate cancer cells
- (2008) Daniel Floryk et al. CANCER LETTERS
- The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism
- (2008) F Chiarini et al. LEUKEMIA
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
- Management of Hodgkin Lymphoma in Relapse after Autologous Stem Cell Transplant
- (2008) M. Crump Hematology-American Society of Hematology Education Program
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started